Secretome from Human Umbilical Cord Mesenchymal Stem Cells Ameliorates Ovarian Aging in a Murine Model
Trends in Sciences · 20.05.2026 · 23 (10) · 13489
DOI: 10.48048/tis.2026.13489 ↗Kurz gefasst
Fachartikel in der Zeitschrift Trends in Sciences, online erschienen am 20.05.2026. Verfasst von Yulice Soraya Nur Intan und 6 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Ovarian aging represents a complex biological process characterized by follicular depletion, hormonal dysregulation, and chronic inflammation. We investigated the therapeutic potential of the secretome derived from human umbilical cord mesenchymal stem cells (S-HUMCMSCs) in naturally aged female mice. Administration of S-HUMCMSCs significantly reduced serum FSH levels (from 5.43 ± 1.59 to 3.07 ± 2.69 mIU/mL, p < 0.05), decreased senescent cell percentage (from 27.35 ± 0.82% to 8.37 ± 0.85%, p < 0.001), and modulated inflammatory markers with reduction in TNF-α (from 188.23 ± 83.31 to 4.55 ± 4.78 ng/mL, p < 0.001) and elevation in IL-10 (7.55 ± 7.77 ng/mL, p < 0.05). Additionally, S-HUMCMSCs treatment decreased p53 expression {179.17 ± 170.48 vs. 549.67 ± 243.62 in aged controls, p < 0.025} and preserved ovarian follicular architecture. A comparative analysis with 17β‑estradiol therapy demonstrated comparable efficacy in improving ovarian parameters. Although no formal toxicological or long‑term safety assessments were conducted, no adverse clinical signs or behavioral abnormalities were observed during the study period. These findings establish S-HUMCMSCs as a promising cell-free regenerative approach for managing age-related ovarian dysfunction by modulating multiple pathways involved in senescence, inflammation, and hormonal homeostasis. HIGHLIGHTS Restoration of HPO Axis Homeostasis: Administration of S-HUMCMSC secretome significantly ameliorated age-related hormonal dysregulation, evidenced by the normalization of serum FSH levels in a naturally aged murine model. Attenuation of Cellular Senescence: The intervention demonstrated potent senolytic properties, significantly reducing the percentage of senescent cells and downregulating p53 expression in ovarian tissue. Modulation of the Inflammatory Microenvironment: S-HUMCMSC therapy shifted the systemic cytokine profile towards an anti-inflammatory state, characterized by a significant reduction in TNF-α and upregulation of IL-10. Comparable Efficacy to 17β‑Estradiol: The cell‑free secretome demonstrated therapeutic efficacy comparable to standard hormone replacement therapy (17β‑estradiol) in preserving follicular architecture, without evidence of adverse effects during the study period. GRAPHICAL ABSTRACT
Zitieren
APA
Intan, Y. S. N., Soetrisno, S., Laqif, A., Indarto, D., Dirgahayu, P., Pamungkasari, E. P., & Putra, A. (2026). Secretome from Human Umbilical Cord Mesenchymal Stem Cells Ameliorates Ovarian Aging in a Murine Model. Trends in Sciences, 23(10), 13489. https://doi.org/10.48048/tis.2026.13489
Vancouver
Intan YSN, Soetrisno S, Laqif A, Indarto D, Dirgahayu P, Pamungkasari EP, et al. Secretome from Human Umbilical Cord Mesenchymal Stem Cells Ameliorates Ovarian Aging in a Murine Model. Trends in Sciences. 2026;23(10):13489. doi:10.48048/tis.2026.13489
BibTeX
@article{Intan2026,
author = {Intan, Yulice Soraya Nur and Soetrisno, Soetrisno and Laqif, Abdurahman and Indarto, Dono and Dirgahayu, Paramasari and Pamungkasari, Eti P. and Putra, Agung},
title = {Secretome from Human Umbilical Cord Mesenchymal Stem Cells Ameliorates Ovarian Aging in a Murine Model},
journal = {Trends in Sciences},
year = {2026},
volume = {23},
number = {10},
pages = {13489},
doi = {10.48048/tis.2026.13489}
}
EUVIMED